Author Correction: The real-world selection of first-line systemic therapy regimen for metastatic gastroenteropancreatic neuroendocrine neoplasm in Japan
Sci Rep. 2022 Dec 19;12(1):21917.
doi: 10.1038/s41598-022-26509-z.
1 Department of Head and Neck, Esophageal Medical Oncology, National Cancer Center Hospital, Tokyo, Japan.
2 Department of Gastrointestinal Medical Oncology, National Cancer Center Hospital, Tokyo, Japan.
3 Division of Health Services Research, Institute for Cancer Control, National Cancer Center, Tokyo, Japan.
4 Department of Hepatobiliary and Pancreatic Oncology, National Cancer Center Hospital, 5-1-1 Tsukiji, Chuo-Ku, Tokyo, 1040045, Japan. [email protected].
5 Department of Hepatobiliary and Pancreatic Oncology, National Cancer Center Hospital, 5-1-1 Tsukiji, Chuo-Ku, Tokyo, 1040045, Japan.
6 Department of Musculoskeletal Oncology and Rehabilitation, National Cancer Center Hospital, Tokyo, Japan.